M. A. Nigro

612 total citations
13 papers, 332 citations indexed

About

M. A. Nigro is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Clinical Biochemistry. According to data from OpenAlex, M. A. Nigro has authored 13 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Clinical Biochemistry. Recurrent topics in M. A. Nigro's work include Metabolism and Genetic Disorders (4 papers), Fetal and Pediatric Neurological Disorders (2 papers) and Genetics and Neurodevelopmental Disorders (2 papers). M. A. Nigro is often cited by papers focused on Metabolism and Genetic Disorders (4 papers), Fetal and Pediatric Neurological Disorders (2 papers) and Genetics and Neurodevelopmental Disorders (2 papers). M. A. Nigro collaborates with scholars based in United States, Italy and Canada. M. A. Nigro's co-authors include M. Z. Jones, Rajesh Sachdeo, Peter Mesenbrink, A. Mancini, G. Geoffroy, David E. Mandelbaum, Luigi De Sio, Lawrence Helson, David Bettis and Loren M. Frank and has published in prestigious journals such as Neurology, Annals of Neurology and European Journal of Cancer.

In The Last Decade

M. A. Nigro

13 papers receiving 314 citations

Peers

M. A. Nigro

PMH

PPCH

MB

CMN

ONCOL

Natan Brand Israel

Dominique Leitner United States

Maria Stella Vari Italy

Sabine Paul Germany

David M. Tishler United States

Yann Nadjar France

Yutaka Hashizume Japan

Aziza Chedrawi Saudi Arabia

M S Patel United States

Emma Footitt United Kingdom

Natan Brand Israel

M. A. Nigro

49 ×0.3

PMH

40 ×0.3

PPCH

109 ×1.1

MB

43 ×0.5

CMN

14 ×0.3

ONCOL

Citations per year, relative to M. A. Nigro M. A. Nigro (= 1×) peers Natan Brand

Countries citing papers authored by M. A. Nigro

Since Specialization

Citations

This map shows the geographic impact of M. A. Nigro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. Nigro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. Nigro more than expected).

Fields of papers citing papers by M. A. Nigro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. A. Nigro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. Nigro. The network helps show where M. A. Nigro may publish in the future.

Co-authorship network of co-authors of M. A. Nigro

This figure shows the co-authorship network connecting the top 25 collaborators of M. A. Nigro. A scholar is included among the top collaborators of M. A. Nigro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. Nigro. M. A. Nigro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Pfund, Zoltán, Harry T. Chugani, Csaba Juhász, et al.. (2000). Lissencephaly. Neurology. 55(11). 1683–1688. 7 indexed citations

2.

Glauser, Tracy A., M. A. Nigro, Rajesh Sachdeo, et al.. (2000). Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology. 54(12). 2237–2244. 134 indexed citations

3.

Floeter, Mary Kay, F. Andermann, E. Andermann, M. A. Nigro, & Maurice B. Hallett. (1996). Physiological studies of spinal inhibitory pathways in patients with hereditary hyperekplexia. Neurology. 46(3). 766–772. 22 indexed citations

4.

Donfrancesco, Alberto, Bruno De Bernardi, Modesto Carli, et al.. (1995). Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: Preliminary results. European Journal of Cancer. 31(4). 612–615. 65 indexed citations

5.

Dixon, Michael J., M. A. Nigro, O. N. Markand, et al.. (1992). Genetic and radiation hybrid mapping of the hyperekplexia region on chromosome 5q.. PubMed. 51(6). 1334–43. 38 indexed citations

6.

Nigro, M. A., et al.. (1991). Colpocephaly in identical twins. Brain and Development. 13(3). 187–189. 12 indexed citations

7.

Munzenberger, Paul J., et al.. (1989). Evaluation of Ames Seralyzer for the therapeutic drug monitoring of phenobarbital and phenytoin.. PubMed. 11(5). 612–5. 2 indexed citations

8.

Martens, Margaret E., P. L. Peterson, C. P. Lee, et al.. (1988). Kearns‐sayre syndrome: Biochemical studies of mitochondrial metabolism. Annals of Neurology. 24(5). 630–637. 19 indexed citations

9.

Nigro, M. A., et al.. (1981). Evidence for defective threonine metabolism in non‐ketotic hyperglycinaemia. Journal of Inherited Metabolic Disease. 6(1). 40–43. 4 indexed citations

10.

Nigro, M. A., et al.. (1981). Screening of high risk infants for metabolic disease in a metropolitan hospital. Journal of Inherited Metabolic Disease. 4(1). 81–82. 2 indexed citations

11.

Jones, M. Z., M. A. Nigro, & Peter S. Barre. (1979). FAMILIAL “GIANT AXONAL NEUROPATHY”. Journal of Neuropathology & Experimental Neurology. 38(3). 324–324. 22 indexed citations

12.

Jones, M. Z., et al.. (1978). PATHOLOGY OF BECKER-TYPE MUSCULAR DYSTROPHY. Journal of Neuropathology & Experimental Neurology. 37(5). 637–637. 2 indexed citations

13.

Berman, Peter H., M. A. Nigro, M. Brennan Harris, & Frank A. Oski. (1973). Activation of Fibrinolysis in Muscular Dystrophy. Archives of Neurology. 29(1). 65–66. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact